You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百济神州(06160.HK)增持合营企业5%股权及偿还股东贷款 共涉逾13亿人币
阿思达克 10-05 08:55
百济神州(06160.HK)公布,於今年9月28日,旗下子公司与凯得订立购股协议,以约1.95亿元人民币(下同)总购买价收购凯得所持有双方合营公司百济神州生物药业的5%股权,及使百济神州生物药业悉数偿还股东贷款及利息,总额约为11.5亿元。

於此项交易完成後,公司将持有百济神州生物药业的100%股权,惟须经当地市场监督管理局批准,预期於今年第四季度取得;股东贷款已悉数偿还并已终止,及公司与凯得订立日期为2017年4月11日的经修订百济神州生物药业股权合资合约将於监管批准日期终止。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account